Nanotechnology is a multidisciplinary field that involves the study of materials 1-1000 nm in diameter in at least one dimension. Over the last few decades, nanotechnology has given rise to promising new therapies and diagnostic tools for a wide range of diseases, especially cancer. The unique properties of nanocarriers such as liposomes, polymeric nanoparticles, micelles, and bioconjugates have mainly been exploited to enhance drug solubility, dissolution, and bioavailability. The most important advantage offered by nanotechnology is the ability to specifically target organs, tissues, and individual cells, which ultimately reduces the systemic side effects and improves the therapeutic index of drug molecules.
The Nanomedicine Lab at ZUJ is headed by Dr. Suhair Sunoqrot, who has extensive research experience in the development of various types of nanocarriers for a variety of applications, including targeted anticancer drug delivery, improved stability, and enhanced solubility. The lab is currently focused on these research themes:
- Bioinspired nanoparticles as novel multifunctional drug delivery nanocarriers.
- Nanoscale solutions for the delivery of poorly water soluble natural and synthetic drug candidates.